REV Group Q3 Results Top Estimates; Boosts FY23 Outlook

RTTNews | 719 dagar sedan
REV Group Q3 Results Top Estimates; Boosts FY23 Outlook

(RTTNews) - REV Group, Inc. (REVG), a manufacturer of specialty vehicles, on Wednesday reported that net income for the third quarter plunged to $14.9 million or $0.25 per share from $9.5 million or $0.16 per share in the prior-year quarter.

Excluding items, adjusted net income for the quarter were $0.35 per share, compared to $0.24 per share in the prior-year quarter.

On average, four analysts polled by Thomson Reuters expected the company to report earnings of $0.23 for the quarter. Analysts' estimates typically exclude special items.

Net sales for the quarter increased to $680.0 million from $594.8 million in the same quarter last year. Analysts expected revenues of $627.16 million for the quarter.

Looking ahead to fiscal 2023, the company now projects net income in a range of $27 million to $37 million and adjusted net income in a range of $63 million to $73 million on net sales between $2.55 billion and $2.60 billion. The Street is looking for revenues of $2.53 billion for the year.

Previously, the company expected net income in the range of $15 million to $30 million and adjusted net income in the range of $48 million to $62 million on net sales between $2.45 billion and $2.55 billion.

The company's board of directors also declared a quarterly cash dividend of $0.05 per share of common stock, payable on October 13, 2023, to shareholders of record on September 29, 2023.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

read more
REV Group Q3 Net Profit More Plunges; Trims FY22 Sales Outlook

REV Group Q3 Net Profit More Plunges; Trims FY22 Sales Outlook

REV Group, Inc. (REVG), a manufacturer of specialty vehicles, on Wednesday reported that net income for the third quarter plunged to $9.5 million or $0.16 per share from $23.7 million or $0.36 per share in the prior-year quarter.
RTTNews | 1090 dagar sedan
DAX Advances; Pharma Stocks Among Notable Gainers

DAX Advances; Pharma Stocks Among Notable Gainers

The German market is modestly higher on Monday, as a U.S. appeals court ruling that many of Donald Trump's tariffs were illegal. Healthcare stocks are finding support after Danish pharma company Novo Nordisk's weight-loss drug Wegovy offered better heart-protective benefits than rival treatments from U.S.-based Eli Lilly.
RTTNews | 2 minuter sedan
U.S. Dollar Falls Amid Rising Fed Rate Cut Bets

U.S. Dollar Falls Amid Rising Fed Rate Cut Bets

The U.S. dollar weakened against other major currencies in the late Asian session on Monday, due to growing speculation that the U.S. Federal Reserve (Fed) may lower interest rates at its September meeting.
RTTNews | 40 minuter sedan
UK House Price Growth Softens In August

UK House Price Growth Softens In August

UK house prices logged a slower pace of growth in August due to stretched affordability, the Nationwide Building Society said Monday. House prices increased 2.1 percent on a yearly basis in August, slower than the 2.4 percent rise seen in July. On a monthly basis, house prices edged down 0.1 percent, in contrast to the 0.5 percent increase in the previous month.
RTTNews | 1h 6minuter sedan
Asian Shares Mixed After US Tech Selloff

Asian Shares Mixed After US Tech Selloff

Asian stocks turned in a mixed performance on Monday as China's factory activity data painted a mixed picture of the world's second-largest economy and investor enthusiasm for artificial intelligence waned.
RTTNews | 1h 59minuter sedan